Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation is a research paper published in Frontiers in Genetics (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Environmental Health Sciences
Grant: R00ES026653 P30 ES026529
Markey Cancer Center, University of Kentucky
Grant: Women Strong Award
NIEHS NIH HHS
Grant: P30 ES026529
NIEHS NIH HHS
Grant: R00 ES026653
National Institutes of Health
Grant: 5R01CA211137-05
Targeting Abl kinases in BRAF-driven melanomas
National Institutes of Health
Grant: 5R00ES026653-04
Mechanisms of mismatch repair mediated cell death after alkylating agent exposure
National Institutes of Health
Grant: 1R01CA258751-01A1
Combating melanoma resistance by targeting ABL1/2
National Institutes of Health
Grant: 5P30ES026529-03
Center for Appalachian Research in Environmental Sciences
National Institutes of Health
Grant: 3P30CA177558-01S1
CTRP Supplement
Fields of Study
Keywords
Sustainable Development Goals